Tag Archives: 5-Fluorouracil

New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

Posted on March 11, 2012 by wngai

Colorectal cancer is the fourth most common cancer in men and women with nearly 500,000 deaths due to colorectal cancer every year. When detected early at localized stage I, the 5-year survival rate can reach 90%. At this stage, surgical … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged 5-Fluorouracil, Avastin, bevacizumab, camptosar, Cetuximab, Eloxatin, Erbitux, gastrointestinal stromal tumors, GIST, Gleevec, imatanib, Irinotecan, leucovorin, metastatic colorectal cancer, oxaliplatin, regoragenib, sunitinib, Survival, Sutent | Comments Off

New Treatment for Colorectal Cancer Patients with Liver Metastases

Posted on April 3, 2011 by wngai

In the past, bevacizumab (Avastin) plus FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) is the mainstay treatment for colorectal cancer patients with metastases (Stage IV). Even though the response rate of this regimen is impressive, less than 10% of Stage IV colorectal cancer … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged 5-Fluorouracil, Avastin, bevacizumab, chemotherapy, FOLFOX, leucovorin, metastatic colorectal cancer, oxaliplatin, radiofrequency ablation, RFA, Survival | Comments Off

A New Treatment Option for patients with Gastric Cancer

Posted on September 12, 2010 by wngai

Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide. Previous study has found that patients with operable disease have a 5-year survival rate of 36%. In patients with advanced or … Continue reading →

Posted in Cancer, Gastric Cancer | Tagged 5-Fluorouracil, capecitabine, chemotherapy, Cisplatin, Gastric Cancer, Gastro-esophageal Junction Cancer, Herceptin, Survival, Trastuzumab, Xeloda | Comments Off

Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer

Posted on May 30, 2010 by wngai

Most elderly breast cancer patients would prefer oral chemotherapy such as capecitabine (Xeloda, Roche) over intravenous chemotherapy due to the convenience. However, a clinical trial conducted in elderly women with early-stage breast cancer has found that standard adjuvant combination chemotherapy … Continue reading →

Posted in Breast cancer, Cancer | Tagged 5-Fluorouracil, 5-FU, Breast cancer, capecitabine, chemotherapy, Cyclophosphamide, doxorubicin, Methotrexate, Survival, Xeloda | Comments Off